v3.25.0.1
Summary of Significant Accounting Policies - Schedule of Percentage of Revenues and Accounts Receivables from Customers (Details) - Customer Concentration Risk
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue | Natera Inc.    
Summary Of Significant Accounting Policies [Line Items]    
Concentration risk percentage 30.00% 43.00%
Revenue | VA MVP    
Summary Of Significant Accounting Policies [Line Items]    
Concentration risk percentage   13.00%
Revenue | Moderna, Inc.    
Summary Of Significant Accounting Policies [Line Items]    
Concentration risk percentage 28.00%  
Accounts Receivable | Natera Inc.    
Summary Of Significant Accounting Policies [Line Items]    
Concentration risk percentage 13.00% 36.00%
Accounts Receivable | Merck & Co., Inc.    
Summary Of Significant Accounting Policies [Line Items]    
Concentration risk percentage 31.00%  
Accounts Receivable | Pfizer Inc.    
Summary Of Significant Accounting Policies [Line Items]    
Concentration risk percentage 25.00%